228
29
th
CONGRESS OF THE ESPU
S3: MISCELLANEOUS
Moderators: Karen Kwak (Netherlands), Alexandra Vermandel (Belgium)
ESPU-Nurses Meeting on Thursday 12, April 2018,
14:00–14:30
14:00–14:10
S3-1 (LO)
MANAGEMENT OF KIDNEY REPLACEMENT TREATMENT
IN BLADDER EXTROPHY
Gemma FERNÁNDEZ MALDONADO, Maria MUÑOZ PÉREZ, Marta CASADO
CARRO, Esther FRANQUET BARNILS, Maria Teresa ALONSO TORRES and Sandra
PÉREZ SANCHO
Fundació Puigvert, Nurse, Barcelona, SPAIN
PURPOSE
Bladder exstrophy is a rare urogenital malformation, more often in males than females (1 to 3). For
the treatment of the disease, reconstructive care in Pediatric Urology is required. Its management
is difficult and complicated, with diverse complications, among them, the Chronic Renal Disease. It
is important to maintain the same care team in the transition stage between the pediatric and adult
age, favors the follow-up of patients and improves their quality of life. Objective: To describe clinical
characteristics, evolution and type of renal replacement therapy in patients with bladder exstrophy.
MATERIAL AND METHODS
A descriptive, retrospective, and Unicentric study in an Uropaediatrics Unit from 1980 to 2016,
in Spain. The study population were all patients diagnosed with exstrophy in renal replacement
therapy. The sample consisted of 4 patients. Sociodemographic variables, clinical care, and com-
plications were collected.
RESULTS
Four cases of bladder exstrophy were studied in renal replacement therapy. 100 % men. The
mean age of onset of CKD was 36 ± 12 years. The initial renal replacement therapy was 100 %
Hemodialysis by Venous Artery Fistula (AVF), at 3.3 ± 1.2 years of diagnosis of the disease (Range
0–5) was performed in 75 % of cases, Renal Transplant, 66, 66 % cadaver donor and 33 % live
donor.
CONCLUSIONS
Nursing professionals should provide care that promotes therapeutic education, promotion, and
prevention of complications of the disease before its occurrence and / or provide tools that contrib-
ute to Improve your quality of life.